Related Experiment Video

Updated: May 23, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
08:45

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation

Published on: June 27, 2025

Complications of chronic liver disease

Alexandra Tsouka1, Valérie A McLin

  • 1Department of Pediatrics, University Hospitals Geneva, 5, rue Willy-Donze, 1205 Geneva, Switzerland.

Clinics and Research in Hepatology and Gastroenterology
|April 24, 2012
PubMed

Insights

Children with chronic liver disease (CLD) require a comprehensive approach, focusing on nutrition and potential multi-organ issues. Early assessment of immune function and heart-lung-brain involvement is crucial for effective management and transplant evaluation.

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine
  • Transplant Surgery

Background:

  • Chronic liver disease (CLD) in children presents complex challenges requiring a holistic management strategy.
  • Early identification of multi-organ involvement is critical for improving patient outcomes.

Purpose of the Study:

  • To emphasize a comprehensive, head-to-toe assessment for pediatric patients with CLD.
  • To highlight the importance of nutritional assessment and management as a cornerstone of care.
  • To underscore the need for considering immune dysfunction and early heart-lung-brain involvement in treatment and transplant evaluations.

Main Methods:

  • Systematic review of current management guidelines for pediatric CLD.
  • Analysis of clinical case studies focusing on multi-organ involvement.
  • Expert consensus on key considerations for nutritional support and immune status.

Main Results:

  • A multidisciplinary approach is essential for managing pediatric CLD.
  • Nutritional assessment and intervention significantly impact disease progression and recovery.
  • Early detection of immune dysfunction and subclinical heart, lung, and brain involvement improves transplant candidacy and outcomes.

Conclusions:

  • Pediatric CLD necessitates a proactive, multi-system approach to care.
  • Prioritizing nutritional status and monitoring for systemic complications are vital.
  • Timely evaluation of immune function and major organ systems is critical for optimizing treatment and transplant success.

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury07:27

The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury

Published on: October 21, 2017

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...